A Self-Selective Spatial–Semantic Deep Prediction Network for Automated Detection and Quantitative Severity Assessment of Bone Sarcoma
A Self-Selective Spatial–Semantic Deep Prediction Network for Automated Detection and Quantitative Severity Assessment of Bone Sarcoma
P. J. Adit,Dr. C. Priya
2026 · DOI: 10.25258/ijddt.16.62s.6
International Journal of Drug Delivery Technology · 0 Citations
TLDR
A Self-Selective Spatial-Semantic Deep Prediction Network (S-DPN) that can be used to automatically detect bone sarcoma and the severity thereof in a quantitative manner and is superior to the conventional deep architectures.
Abstract
Background
Bone Sarcoma is a most common primary bone tumor with complex spatial morphology, heterogeneous tissueconstitution, which complicates the process of localizing the tumor very well and objectively determining theirseverity in histopathological images. Existing systems of deep learning are predominantly performing single taskssuch as classification or segmentation without a cohesive system capable of simultaneously measuring multi-scalespatial structure and high-level semantic malignancy features to inform severity-sensitive diagnosis.ObjectiveTo deal with this shortcoming, this research will propose a Self-Selective Spatial-Semantic Deep PredictionNetwork (S-DPN) that can be used to automatically detect bone sarcoma and the severity thereof in a quantitativemanner.Materials and MethodsThe architecture has parallel spatial and semantic encoders to achieve structural features, which are related to tumorshape, irregularity of the periphery and the pattern around them, which are linked with malignancy of the tissues.Self-selective attention process is an adaptive process whereby there is stressing of clinically relevant areas andinhibition of background noises followed by weighted spatial and semantic fusion. The combined features not onlyaid in the appropriate localization of the tumor, but also in the determination of the severity of the tumor inpercentage of the affected bone tissue that can be interpreted as a clinical value. S-DPN adequately addresses thelimitations in the prediction of tumor presence and a quantitative measure of the severity of the tumor by jointlyoptimizing both detection and severity estimation in an end-to-end learning system.ResultsThe experimental findings on publicly accessible bone sarcoma histopathology dataset indicate that the proposedmodel has accuracy of 98.7% and it is superior to the conventional deep architectures.ConclusionThe S-DPN provides clinically informative severity-conscious, high-quality bone sarcoma determination to supportcorrect diagnosis and treatment planning.